Heart Rate Control With Esmolol in Septic Shock
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 154 participants.
Also called NCT01231698
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 154 participants
- Sponsor
- Andrea Morelli
- Registry
-
NCT01231698
-
- Other papers using this trial's data
- Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: a randomized clinical trial
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Italy
- Registry status
- Completed
Technical summary
Registry record NCT01231698. Randomized; no masking; primary purpose treatment. Start 2010-12 (registry gives no type); primary completion 2012-07 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Heart Rate Control With Esmolol in Septic Shock
- Condition
- Septic Shock
- Intervention (Drug)
- esmolol
- Intervention (Other)
- control
- Lead sponsor
- Andrea Morelli
Record details
- Record id
cardio:ct-nct01231698- Content hash
4db0df9d6572906d1a6ee265393062735e18a195091fab0f048b44ad485b5ade